| ubiquitin-like protein ligase binding | GO:0044389 | 4.15 |
| adrenergic receptor binding | GO:0031690 | 6.85 |
| 3',5'-cyclic-nucleotide phosphodiesterase activity | GO:0004114 | 6.52 |
| 3',5'-cyclic-AMP phosphodiesterase activity | GO:0004115 | 7.03 |
| cyclic-nucleotide phosphodiesterase activity | GO:0004112 | 6.48 |
| beta-2 adrenergic receptor binding | GO:0031698 | 8.13 |
| phosphoric ester hydrolase activity | GO:0042578 | 3.82 |
| binding | GO:0005488 | 0.18 |
| G-protein coupled receptor binding | GO:0001664 | 4.18 |
| ion channel binding | GO:0044325 | 5.02 |
| nucleotide binding | GO:0000166 | 1.96 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| nucleoside phosphate binding | GO:1901265 | 1.96 |
| cation binding | GO:0043169 | 1.4 |
| phosphoric diester hydrolase activity | GO:0008081 | 5.23 |
| ion binding | GO:0043167 | 1.36 |
| adenyl ribonucleotide binding | GO:0032559 | 2.41 |
| metal ion binding | GO:0046872 | 1.41 |
| hydrolase activity | GO:0016787 | 1.9 |
| ATPase binding | GO:0051117 | 5.41 |
| hydrolase activity, acting on ester bonds | GO:0016788 | 3.1 |
| small molecule binding | GO:0036094 | 1.89 |
| catalytic activity | GO:0003824 | 1.05 |
| enzyme binding | GO:0019899 | 2.27 |
| purine nucleotide binding | GO:0017076 | 2.19 |
| drug binding | GO:0008144 | 5.03 |
| cAMP binding | GO:0030552 | 6.56 |
| cyclic nucleotide binding | GO:0030551 | 6.13 |
| ubiquitin protein ligase binding | GO:0031625 | 4.17 |
| adenyl nucleotide binding | GO:0030554 | 2.4 |
| carbohydrate derivative binding | GO:0097367 | 2.03 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| scaffold protein binding | GO:0097110 | 5.93 |
| protein binding | GO:0005515 | 0.46 |
| purine ribonucleotide binding | GO:0032555 | 2.2 |
| receptor binding | GO:0005102 | 2.43 |
| ribonucleotide binding | GO:0032553 | 2.19 |